Abstract
The clinical significance of quality of life changes has little to do with the QOL as a measure, but is rather a reflection on the novelty of the measures and researcher's inexperience in their use. This article discusses possible ways of evaluating quality of life measures in terms of patient-clinician interactions and how the clinician can assess the importance of these changes of QOL in terms of treatment and management of disease.
Similar content being viewed by others
References
Testa MA. Interpreting quality-of-life clinical trial data for use in the clinical practice of antihypertensive therapy. J Hypertens 1987; 5(Suppl 1): S9-S13.
Ware JEJr, Manning WGJr, Duan N, Wells KB, Newhouse JP. Health status and the use of outpatient mental health services. Am Psychol 1984; 39: 1090–1100.
Salsburg DS, Turner RS. Defining clinical meaningful units of change for health outcome research. Quality of Life Newsletter 1992; 3: 1.
Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston/Toronto: Little, Brown & Co, 1985: 181–182.
Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12–19.
Jaeschke R, Singer J, Guyatt GH. Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trial 1989; 10: 407–415.
Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327: 1185–1191.
Girman CJ, Panser LA, Chute CG, et al. Natural history of prostatism: Urinary flow rates in a community-based study. J Urology (in press).
Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27: S178-S189.
Testa MA, Lenderking WR. Interpreting pharmacoeconomic and quality-of-life clinical trial data for use in therapeutics. PharmacoEconomics 1992; 2: 107–117.
Brook RH, Ware JEJr, Rogers WH, et al. Does free care improve adults' health? Results from a randomized controlled trial. N Engl J Med 1983; 309: 1426–1434.
Cleeland CS. Assessment of pain in cancer measurement issues. Adv Pain Res Ther 1990; 16: 47–55.
Spitz PW, Fries JF. The present and future comprehensive outcome measures for rheumatic diseases. Clin Rheumatol 1987; 6(Suppl 2): 105–11.
Marder SR, Mintz J, VanPutten R, Lebell M, Wirshing WC, Johnston-Cronk K. Early prediction of relapse in schizophrenia: an application of receiver operating characteristics (ROC) methods. Psychopharmacol Bull 1991; 27: 79–82.
Deyo RA, Inui TS. Toward clinical applications of health status measures: sensitivity of scales to clinical important changes. Health Svcs Res 1984; 19: 275–289.
Guyatt G, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chron Dis 1987; 40: 171–178.
Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II. Design, analysis, and interpretation. Br Med J 1992; 305: 1145–1148.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lydick, E., Epstein, R.S. Interpretation of quality of life changes. Qual Life Res 2, 221–226 (1993). https://doi.org/10.1007/BF00435226
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00435226